Evidence map›Paper›PMID 31027270›Full record

ReviewMolecules (Basel, Switzerland)2019

…Fell Upas Sits, the Hydra-Tree of Death

Vadim G Lebedev, Konstantin V Krutovsky, Konstantin A Shestibratov

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Vadim G LebedevForest Biotechnology Group, Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 6 Prospect Nauki, Pushchino, 142290 Moscow, Russia. vglebedev@mail.ru.
Konstantin V KrutovskyDepartment of Forest Genetics and Forest Tree Breeding, Georg-August University of Göttingen, Büsgenweg 2, 37077 Göttingen, Germany. konstantin.krutovsky@forst.uni-goettingen.de.ORCID 0000-0002-8819-7084
Konstantin A ShestibratovForest Biotechnology Group, Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 6 Prospect Nauki, Pushchino, 142290 Moscow, Russia. schestibratov.k@yandex.ru.
Institute of Bioorganic Chemistry · RUVavilov Institute of General Genetics · RU

Funding

Ministry of Science and High Education of the Russian Federation 0101-2019-0037
6 · The paper itself

Abstract

The use of natural products that can serve as natural herbicides and insecticides is a promising direction because of their greater safety for humans and environment. Secondary metabolites of plants that are toxic to plants and insects-allelochemicals-can be used as such products. Woody plants can produce allelochemicals, but they are studied much less than herbaceous species. Meanwhile, there is a problem of interaction of woody species with neighboring plants in the process of introduction or invasion, co-cultivation with agricultural crops (agroforestry) or in plantation forestry (multiclonal or multispecies plantations). This review describes woody plants with the greatest allelopathic potential, allelochemicals derived from them, and the prospects for their use as biopesticides. In addition, the achievement of and the prospects for the use of biotechnology methods in relation to the allelopathy of woody plants are presented and discussed.

Indexed as

Biological ProductsHerbicidesPlants, Genetically ModifiedTreesBiological ProductsHerbicidesallelopathybiopesticidesherbicidal activityinsecticidal activitysecondary methabolitstransgenic plantstree species

Identifiers

PMID31027270
PMCPMC6514861
OpenAlexW2942239049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.